Table 2

Tetramer staining of the 10 vaccinated patients in this trial

Patient no.Before first vaccinationAfter first vaccinationAfter second vaccinationAfter third vaccinationAfter fourth vaccinationImmune response
1 0.05 nt 0.03 0.06 0.11 Positive 
2 0.54 0.46 0.51 0.73 0.63 Positive 
3 0.46 0.65 0.42 0.7 nt Positive 
4 0.48 nt 0.48 0.52 nt No change 
5 nt nt nt nt nt nt 
6 0.33 0.28 0.29 0.42 0.31 Positive 
7 0.16 0.13 0.16 0.15 0.13 No change 
8 0.55 0.41 0.40 1.23 0.46 Positive 
9 0.06 0.14 0.13 0.09 0.11 Positive 
10 0.28 0.53 0.47 0.38 0.56 Positive 
Patient no.Before first vaccinationAfter first vaccinationAfter second vaccinationAfter third vaccinationAfter fourth vaccinationImmune response
1 0.05 nt 0.03 0.06 0.11 Positive 
2 0.54 0.46 0.51 0.73 0.63 Positive 
3 0.46 0.65 0.42 0.7 nt Positive 
4 0.48 nt 0.48 0.52 nt No change 
5 nt nt nt nt nt nt 
6 0.33 0.28 0.29 0.42 0.31 Positive 
7 0.16 0.13 0.16 0.15 0.13 No change 
8 0.55 0.41 0.40 1.23 0.46 Positive 
9 0.06 0.14 0.13 0.09 0.11 Positive 
10 0.28 0.53 0.47 0.38 0.56 Positive 

Immune response: an initial value less than 0.1% was judged positive if there was a consecutive increase more than 50%; an initial value more than 0.1% was judged positive if there was a consecutive increase more than 25%.

nt indicates not tested, that is, not sufficient cells for tetramer staining (apart from ELISpot assays).

View Large
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal